NewAmsterdam Pharma N.V.
(NAMSW)
undefined
undefined%
At close: undefined
13.02
-3.41%
After-hours Dec 13, 2024, 03:03 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
PE Ratio | -1.30 | -2.45 | -1.18 | -8.19 |
PS Ratio | 17.98 | 0.54 | 0.00 | 0.00 |
PB Ratio | 0.80 | 0.11 | 0.87 | -13.17 |
P/FCF Ratio | -1.62 | 6.49 | -1.72 | -7.87 |
P/OCF Ratio | -1.62 | 6.48 | -1.72 | -7.89 |
OCF/S Ratio | -2.77 | 0.02 | 0.00 | 0.00 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | -0.81 |
Quick Ratio | 1.74 | 3.16 | 1.49 | 0.18 |
Current Ratio | 1.74 | 3.16 | 1.49 | 0.18 |
Asset Turnover | 0.04 | 0.18 | 0.00 | 0.00 |
Interest Coverage | -6.09 | 0.00 | 0.00 | 0.00 |
Return on Equity (ROE) | -61.35% | -4.36% | -73.73% | 160.72% |
Return on Assets (ROA) | -50.98% | -3.98% | -61.41% | -62.28% |
Return on Capital (ROIC) | -55.76% | -0.67% | -61.58% | 151.78% |
Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | 25.00% | 25.00% | 0.00% | 0.00% |
Net Profit Margin | -346.59% | -5.51% | 0.00% | 0.00% |